Retour
Fourchette du Jour
10,56 €
11,60 €
Fourchette 52 Semaines
2,21 €
18,31 €
Volume
794 084
Moyenne 50J / 200J
12,61 €
/
12,18 €
Clôture Précédente
11,21 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,8 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | -126,4 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
23,33 €
+120.7%
Low: 16,00 €
High: 28,00 €
BPA Prévisionnel
-0,05 €
CA Est.
330 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,93 €
4,68 € – 5,20 €
|
1 B | 2 |
| FY2029 |
4,13 €
3,92 € – 4,35 €
|
890 M | 4 |
| FY2028 |
3,07 €
2,15 € – 4,25 €
|
750 M | 6 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 |
Parikh Asit
|
other | 80 000 | — | — |
| Feb 10, 2026 |
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
|
grant | 3 461 | — | — |
| Feb 10, 2026 |
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
|
other | 1 535 | 12,82 € | 19 679 € |
| Feb 10, 2026 |
Basta Steven L
President and CEO
|
grant | 12 362 | — | — |
| Feb 10, 2026 |
Basta Steven L
President and CEO
|
other | 6 277 | 12,82 € | 80 471 € |
| Jan 23, 2026 |
Parikh Asit
|
other | 161 000 | — | — |
| Jan 21, 2026 |
Breedlove Robert Charles
Principal Accounting Officer
|
other | 776 | 13,61 € | 10 561 € |
| Jan 13, 2026 |
Parikh Asit
|
other | 17 500 | 10,30 € | — |
| Jan 2, 2026 |
Basta Steven L
President and CEO
|
grant | 477 190 | — | — |
| Jan 2, 2026 |
Narula Sanjeev
Chief Financial & Bus. Officer
|
grant | 125 563 | — | — |
| Dec 19, 2025 |
Parikh Asit
|
other | 17 500 | 10,30 € | — |
| Dec 18, 2025 |
Breedlove Robert Charles
Principal Accounting Officer
|
other | 230 | 16,28 € | 3 744 € |
| Dec 17, 2025 |
Basta Steven L
President and CEO
|
other | 31 502 | 15,36 € | 483 871 € |
| Dec 17, 2025 |
Basta Steven L
President and CEO
|
grant | 62 038 | — | — |
| Nov 28, 2025 |
Basta Steven L
President and CEO
|
other | 228 375 | — | — |
| Nov 3, 2025 |
Breedlove Robert Charles
Principal Accounting Officer
|
sell | 524 | 13,51 € | 7 079 € |
| Oct 6, 2025 |
Narula Sanjeev
Chief Financial & Bus. Officer
|
grant | 344 000 | — | — |
| Sep 25, 2025 |
Basta Steven L
President and CEO
|
other | 228 375 | — | — |
| Sep 5, 2025 |
Breedlove Robert Charles
Principal Accounting Officer
|
sell | 461 | 12,09 € | 5 573 € |
| Jul 16, 2025 |
Breedlove Robert Charles
Principal Accounting Officer
|
sell | 1 692 | 8,36 € | 14 152 € |
Points Clés
Negative free cash flow of -166,78M
PEG of 0,13 suggests growth is underpriced
Capital efficient — spends only 0,13% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)216,93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net Margin-126,35%
Op. Margin-91,36%
Sécurité
Debt / Equity
N/A
Current Ratio1,73
Interest Coverage-2,35
Valorisation
P/E Ratio
-3,76
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 216,93% | Revenue Growth (3Y) | 1502,37% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 175,11M | Net Income (TTM) | -221,25M |
| ROE | N/A | ROA | -85,37% |
| Gross Margin | 87,09% | Operating Margin | -91,36% |
| Net Margin | -126,35% | Free Cash Flow (TTM) | -166,78M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,73 |
| Interest Coverage | -2,35 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,76 | P/B Ratio | N/A |
| P/S Ratio | 4,76 | PEG Ratio | 0,13 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 832,90M | Enterprise Value | 705,64M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 175,11M | 55,25M | 682 000,0 | 0,0 | 0,0 |
| Net Income | -221,25M | -334,33M | -201,59M | -197,72M | -143,88M |
| EPS (Diluted) | -3,03 | -5,29 | -3,93 | -5,70 | -4,00 |
| Gross Profit | 152,51M | 47,28M | 515 000,0 | -620 000,0 | -521 000,0 |
| Operating Income | -159,99M | -277,47M | -167,31M | -172,44M | -135,08M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 259,15M | 378,32M | 413,84M | 164,81M | 189,43M |
| Total Liabilities | 697,32M | 631,90M | 486,60M | 239,62M | 117,28M |
| Shareholders' Equity | -438,17M | -253,58M | -72,76M | -74,81M | 72,16M |
| Total Debt | 2,71M | 554,95M | 139,03M | 97,07M | 91,34M |
| Cash & Equivalents | 129,97M | 297,26M | 381,39M | 155,39M | 183,26M |
| Current Assets | 228,97M | 360,13M | 397,43M | 160,51M | 186,53M |
| Current Liabilities | 132,04M | 85,73M | 38,78M | 26,24M | 18,92M |